title: A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis.
abstract: BACKGROUND
  In 1991, consensus guidelines recommended psoralen plus ultraviolet A photochemotherapy (PUVA) for those requiring second-line therapy for psoriasis. Narrowband (TL-01) UVB has since become more widely available, replacing the less effective broadband sources. Objectives To compare the efficacy of TL-01 UVB phototherapy and trimethoxypsoralen (TMP) bath-PUVA for chronic plaque psoriasis.
  
  
  METHODS
  A randomized, observer-masked, intraindividually controlled, paired (half-body) study was done in the Photo(chemo)therapy Unit in Ninewells Hospital and Medical School, Dundee. The study comprised 28 patients (skin phototypes I-III) with chronic plaque psoriasis. Each patient's body halves (sagittal plane) were treated independently, one-half with TL-01 UVB, the other with bath-PUVA. Both treatments were administered according to standard, optimized regimens. Treatment was continued until clearance or minimal residual activity (MRA), or a maximum of 30 treatments. The main outcome measures were treatments and time to clearance/MRA, the proportion reaching clearance/MRA, change in psoriasis severity score (scaling, erythema and induration) and remission durations.
  
  
  RESULTS
  Of 18 who completed the study, all reached clearance/MRA with TL-01, but three were still not clear after 30 PUVA exposures. TL-01 achieved clearance/MRA a median of 11 (6.5-25; P = 0.001) days more quickly than PUVA, but required a median of 24.5 compared with 19 exposures [95% confidence interval (CI) for difference 1.5-5.5; P = 0.01]. Ten patients were withdrawn (four because of inadequate response of PUVA-treated halves). Analysed on an intention-to-treat basis, 21 of 28 (75%) of all participants reached clearance/MRA with TL-01 compared with 15 of 28 (54%) with PUVA (95% CI for difference 4-37%; P = 0.03). Remission durations did not differ.
  
  
  CONCLUSIONS
  When administered according to these regimens in a skin phototype I-III population, TL-01 UVB is more efficacious than TMP bath-PUVA in the treatment of chronic plaque psoriasis.
authors.affiliation: Department of Dermatology, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. r.s.dwe@dundee.ac.uk
authors.forename: R S
authors.initials: RS
authors.lastname: Dawe
authors.forename: H
authors.initials: H
authors.lastname: Cameron
authors.forename: S
authors.initials: S
authors.lastname: Yule
authors.forename: I
authors.initials: I
authors.lastname: Man
authors.forename: N J
authors.initials: NJ
authors.lastname: Wainwright
authors.forename: S H
authors.initials: SH
authors.lastname: Ibbotson
authors.forename: J
authors.initials: J
authors.lastname: Ferguson
mesh_terms: D000328:Adult; D000368:Aged; D001452:Balneology / Q000379:methods; D005260:Female; D005363:Ficusin / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy / Q000379:methods*; D017060:Patient Satisfaction; D017319:Photosensitizing Agents / Q000008:administration & dosage*; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome; D014466:Ultraviolet Rays
chemical_list: D017319:Photosensitizing Agents; D005363:Ficusin